Evidence map›Paper›PMID 35013872›Full record

ArticleParasitology research2022

Lethality among individuals infected with visceral leishmaniasis in Brazil: a retrospective study (2007-2018).

Luciana Silami Carvalho, Maria das Graças Braga, Dário Alves da Silva Costa, Taynãna César Simões, Mariana Dias Lula, Micheline Rosa Silveira

Abstract read
PubMed Publisher
In one paragraph

Article in Parasitology research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Luciana Silami CarvalhoSocial Pharmacy Department, Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil. lucianacarvalho1803@gmail.com.ORCID http://orcid.org/0000-0003-3707-7434
Maria das Graças BragaSocial Pharmacy Department, Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Dário Alves da Silva CostaRené Rachou Institute, Fiocruz Minas Gerais, Belo Horizonte, Brazil.
Taynãna César SimõesRené Rachou Institute, Fiocruz Minas Gerais, Belo Horizonte, Brazil.
Mariana Dias LulaSocial Pharmacy Department, Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Micheline Rosa SilveiraSocial Pharmacy Department, Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil.

Funding

Universidade Federal de Minas Gerais Departamento de Farmácia
6 · The paper itself

Abstract

Visceral leishmaniasis (VL) is a public health problem with a high prevalence and lethality in Brazil. This study aims to estimate the lethality and associated factors in individuals with VL and assess survival time, emphasizing VL/HIV coinfection. This retrospective study has 37,583 individuals notified and confirmed with VL in the Sistema de Informação de Agravos de Notificação (SINAN) between 2007 and 2018 (Brazil). Lethality was evaluated considering VL deaths, deaths from other causes (OC), and non-deaths. We performed a multinomial logistic regression, with non-death as the benchmark category. We conducted a survival analysis (Kaplan-Meier method), emphasizing VL/HIV coinfection. Most individuals were young, male, mixed race, low schooling level, and urban dwellers. The lethality rate was 10.2% (VL and OC deaths) and 7.8% (VL deaths). The prevalence of HIV infection was 8.81%. A higher likelihood of VL and OC deaths was observed in older age groups, females, and with a higher number of symptoms. A higher likelihood of OC deaths was identified in individuals with HIV. A lower likelihood of VL and OC deaths was observed for individuals on VL therapy. The mean survival time was longer for VL/HIV individuals, who had a lower survival rate than those with VL. The data point to the need for attention to the timely diagnosis of VL and HIV and adequate pharmacological treatment in this population.

Indexed as

CoinfectionHIV InfectionsLeishmaniasis, VisceralAgedBrazilFemaleHumansMaleRetrospective StudiesHIVLethalityPrevalenceSurvivalVisceral leishmaniasis

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.